These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4602108)

  • 1. Oxprenolol and ventricular ectopic activity of the heart.
    Myburgh DP
    S Afr Med J; 1974 May; 48(25):1073-4. PubMed ID: 4602108
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia.
    Sandler G; Pistevos AC
    Br Med J; 1971 Jan; 1(5743):254-7. PubMed ID: 5100496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience.
    Bethge KP; Andresen D; Boissel JP; von Leitner ER; Peyrieux JC; Schröder R; Tietze U
    J Am Coll Cardiol; 1985 Nov; 6(5):963-72. PubMed ID: 2413097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic blockade for survivors of acute myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    N Engl J Med; 1984 Mar; 310(13):830-7. PubMed ID: 6142420
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trasicor in acute supraventricular arrhythmias].
    Sukenik S; Cristal N
    Harefuah; 1975 Sep; 89(6):250-2. PubMed ID: 1165071
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulatory collapse after oral oxprenolol.
    Brooks NH
    Br Med J; 1975 Oct; 4(5987):24. PubMed ID: 1174909
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled evaluation of the beta adrenoceptor blocking drug oxprenolol in anxiety.
    Johnson G; Singh B; Leeman M
    Med J Aust; 1976 Jun; 1(24):909-12. PubMed ID: 790112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality.
    Eur Heart J; 1984 Mar; 5(3):189-202. PubMed ID: 6373264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An early intervention secondary prevention study with oxprenolol following myocardial infarction.
    Eur Heart J; 1981 Oct; 2(5):389-93. PubMed ID: 7037414
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Gettes LS
    Cardiovasc Clin; 1970; 2(2):211-37. PubMed ID: 4149974
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oxprenolol in the treatment and prevention of cardiac arrhythmias].
    Martinoli E; Medugno G; Crepaldi L; Scardi S; Camerini F
    Minerva Med; 1975 Oct; 66(68):3566-73. PubMed ID: 52854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the effects of oxprenolol on pain and on electrocardiographic changes in patients with ischemic heart disease].
    Contino A
    G Clin Med; 1979 May; 60(5):402-8. PubMed ID: 488590
    [No Abstract]   [Full Text] [Related]  

  • 14. Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
    Tuna JL; Correia MJ; d'Almeida VC; Mourão L; da Costa FL; Ribeiro C
    Acta Med Port; 1980 Dec; Suppl 1():27-32. PubMed ID: 6164252
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of trasycor in disorders of the cardiac rhythm and ischemic heart disease].
    Fomina AA; Spivak AM; Mironova KA; Reingardt BK
    Vrach Delo; 1974 Jun; (6):46-9. PubMed ID: 4466091
    [No Abstract]   [Full Text] [Related]  

  • 16. [Abnormal ECG and adrenaline-induced arrhythmias in restraint and water immersion stressed mice and effects of oxprenolol].
    Kita T; Hata T; Harada N; Itoh E
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):373-82. PubMed ID: 6147301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacology of a new beta-adrenergic blocking agent--Trasicor].
    Votchal BE; Zamotaev IP; Lozinskiĭ LG; Sandomirskiĭ BL; Vorob'eva ZV
    Ter Arkh; 1973 Aug; 45(8):10-4. PubMed ID: 4149629
    [No Abstract]   [Full Text] [Related]  

  • 18. [An example of an acceptable combination in the treatment of arterial hypertension].
    Menard J; Plouin PF; Gouin F; Corvol P; Milliez P
    Sem Hop; 1978 Feb; 54(4):201-6. PubMed ID: 208167
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of a beta-blocking agent, oxprenolol, in the treatment of rhythm disorders].
    Broustet P; Lacut JY
    Bord Med; 1972 Oct; 5(16):2131-9. PubMed ID: 4640792
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of disorders of cardiac rhythm with beta-adrenoblockaders].
    Zamotaev IP; Lozinskiĭ LG; Sandomirskiĭ BL
    Klin Med (Mosk); 1985 Aug; 63(8):41-8. PubMed ID: 2867248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.